• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

养老机构中痴呆患者伤害预防(NH PRIDE):一项针对 NH 居民远程伤害预防服务的试点研究。

Nursing Home PRevention of Injury in DEmentia (NH PRIDE): A pilot study of a remote injury prevention service for NH residents.

机构信息

Hinda and Arthur Marcus Institute for Aging Research and Department of Medicine, Hebrew SeniorLife, Boston, Massachusetts, USA.

Department of Medicine & Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.

出版信息

J Am Geriatr Soc. 2023 Oct;71(10):3267-3277. doi: 10.1111/jgs.18564. Epub 2023 Aug 19.

DOI:10.1111/jgs.18564
PMID:37596877
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10592133/
Abstract

BACKGROUND

Medication optimization, including prescription of osteoporosis medications and deprescribing medications associated with falls, may reduce injurious falls. Our objective was to describe a remote, injury prevention service (NH PRIDE) designed to optimize medication use in nursing homes (NHs), and to describe its implementation outcomes in a pilot study.

METHODS

This was a non-randomized trial (pilot study) including NH staff and residents from five facilities. Long-stay residents at high-risk for injurious falls were identified using a validated risk calculator and staff referral. A remote team reviewed the electronic health record (EHR) and provided recommendations as Injury Prevention Plans (IPP). A research nurse served as a care coordinator focused on resident engagement and shared decision-making. Outcomes included implementation measures, as identified in the EHR, and surveys and interviews with staff.

RESULTS

Across five facilities, 274 residents were screened for eligibility, and 46 residents (16.8%) were enrolled. Most residents were female (73.9%) and had dementia (63.0%). An IPP was completed for 45 residents (97.8%). The nurse made a total of 93 deprescribing recommendations in 36 residents (80% of residents had one or more deprescribing recommendation; mean 2.2 recommendations/resident). Twenty of 45 residents (44.4%) had a recommendation for osteoporosis treatment. Among residents with recommendations, 21/36 (58.3%) had one or more deprescribing orders written and 6/20 (30.0%) had an osteoporosis medication prescribed. At 4 months, most medication changes persisted. Adverse side effects were rare. Staff members identified several areas for program refinement, including aligning recommendations with provider workflow and engaging consultant psychiatrists.

CONCLUSIONS

A remote injury prevention service is safe and feasible to enhance deprescribing and osteoporosis treatment in long-stay NH residents at risk for injury. Additional investigation is needed to determine if this model could reduce injurious falls when deployed across NH chains.

摘要

背景

药物优化,包括骨质疏松症药物的处方和与跌倒相关的药物停用,可能会减少伤害性跌倒。我们的目的是描述一种远程的、预防伤害的服务(NH PRIDE),旨在优化养老院(NH)的药物使用,并在一项试点研究中描述其实施结果。

方法

这是一项非随机试验(试点研究),包括来自五家机构的 NH 工作人员和居民。使用经过验证的风险计算器和工作人员推荐,确定有高伤害性跌倒风险的长期住院患者。一个远程团队审查电子健康记录(EHR)并提供作为伤害预防计划(IPP)的建议。一名研究护士担任护理协调员,专注于居民参与和共同决策。结果包括实施措施,这些措施在 EHR 中确定,并对工作人员进行调查和访谈。

结果

在五家机构中,对 274 名居民进行了资格筛选,其中 46 名居民(16.8%)入组。大多数居民为女性(73.9%),患有痴呆症(63.0%)。为 45 名居民(97.8%)完成了 IPP。护士共在 36 名居民(80%的居民有一项或多项药物停用建议;平均每位居民 2.2 项建议)中提出了 93 项药物停用建议。45 名居民中有 20 名(44.4%)有骨质疏松症治疗建议。在有建议的居民中,36 名居民中有 21 名(58.3%)开出了一项或多项药物停用医嘱,20 名居民中有 6 名(30.0%)开出了骨质疏松症药物处方。在 4 个月时,大多数药物变化仍在继续。不良反应很少见。工作人员确定了几个计划改进的领域,包括使建议与提供者的工作流程保持一致以及让顾问精神科医生参与。

结论

远程伤害预防服务是安全可行的,可以增强有受伤风险的长期住院 NH 居民的药物停用和骨质疏松症治疗。需要进一步研究以确定该模型在 NH 连锁机构中部署时是否可以减少伤害性跌倒。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4645/10592133/43e2392ad7c1/nihms-1925375-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4645/10592133/2a6531891f3b/nihms-1925375-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4645/10592133/055e787844b3/nihms-1925375-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4645/10592133/43e2392ad7c1/nihms-1925375-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4645/10592133/2a6531891f3b/nihms-1925375-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4645/10592133/055e787844b3/nihms-1925375-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4645/10592133/43e2392ad7c1/nihms-1925375-f0003.jpg

相似文献

1
Nursing Home PRevention of Injury in DEmentia (NH PRIDE): A pilot study of a remote injury prevention service for NH residents.养老机构中痴呆患者伤害预防(NH PRIDE):一项针对 NH 居民远程伤害预防服务的试点研究。
J Am Geriatr Soc. 2023 Oct;71(10):3267-3277. doi: 10.1111/jgs.18564. Epub 2023 Aug 19.
2
Risk for Health Events After Deprescribing Acetylcholinesterase Inhibitors in Nursing Home Residents With Severe Dementia.在患有严重痴呆的养老院居民中停用乙酰胆碱酯酶抑制剂后的健康事件风险。
J Am Geriatr Soc. 2020 Apr;68(4):699-707. doi: 10.1111/jgs.16241. Epub 2019 Nov 26.
3
Patterns of oral bisphosphonate deprescribing in older nursing home residents with dementia.老年痴呆症护理院居民中口服双膦酸盐药物减量模式。
Osteoporos Int. 2022 Feb;33(2):379-390. doi: 10.1007/s00198-021-06141-9. Epub 2021 Sep 4.
4
Prescriber Perspectives and Experiences with Deprescribing Versus Continuing Bisphosphonates in Older Nursing Home Residents with Dementia.在患有痴呆症的老年疗养院居民中,停止使用 vs 继续使用双膦酸盐药物的处方者观点和经验。
J Gen Intern Med. 2023 Nov;38(15):3372-3380. doi: 10.1007/s11606-023-08275-4. Epub 2023 Jun 27.
5
Effects of an interprofessional deprescribing intervention in Swiss nursing homes: the Individual Deprescribing Intervention (IDeI) randomised controlled trial.瑞士养老院中开展的一项跨专业药物精简干预措施的效果:个体药物精简干预(IDeI)随机对照试验。
BMC Geriatr. 2021 Nov 19;21(1):655. doi: 10.1186/s12877-021-02465-7.
6
Deprescribing in nursing homes: Protocol for nested, randomised controlled hybrid trials of deprescribing interventions.养老院中的减药方案:嵌套随机对照混合试验研究减药干预措施的方案。
Res Social Adm Pharm. 2021 Apr;17(4):786-794. doi: 10.1016/j.sapharm.2020.05.026. Epub 2020 May 27.
7
Effects of an interprofessional Quality Circle-Deprescribing Module (QC-DeMo) in Swiss nursing homes: a randomised controlled trial.跨专业质量圈-减药模块(QC-DeMo)对瑞士养老院的影响:一项随机对照试验。
BMC Geriatr. 2021 May 1;21(1):289. doi: 10.1186/s12877-021-02220-y.
8
The OptimaMed intervention to reduce inappropriate medications in nursing home residents with severe dementia: results from a quasi-experimental feasibility pilot study.《OptimaMed 干预措施减少重症痴呆养老院居民的不适当药物使用:一项准实验可行性试点研究结果》。
BMC Geriatr. 2018 Sep 4;18(1):204. doi: 10.1186/s12877-018-0895-z.
9
Balancing medication use in nursing home residents with life-limiting disease.平衡患有绝症的养老院居民的药物使用。
Eur J Clin Pharmacol. 2019 Jul;75(7):969-977. doi: 10.1007/s00228-019-02649-6. Epub 2019 Mar 4.
10
Deprescribing of Antihypertensive Medications and Cognitive Function in Nursing Home Residents.降压药物停用与养老院居民认知功能。
JAMA Intern Med. 2024 Nov 1;184(11):1347-1355. doi: 10.1001/jamainternmed.2024.4851.

引用本文的文献

1
Fall Risk Assessment and Prevention Strategies in Nursing Homes: A Narrative Review.养老院中的跌倒风险评估与预防策略:一项叙述性综述
Healthcare (Basel). 2025 Feb 7;13(4):357. doi: 10.3390/healthcare13040357.

本文引用的文献

1
Fracture liaison service model: treatment persistence 5 years later.骨折联络服务模式:5 年后的治疗坚持情况。
Arch Osteoporos. 2021 Apr 4;16(1):60. doi: 10.1007/s11657-021-00925-6.
2
Validation of the Minimum Data Set Items on Falls and Injury in Two Long-Stay Facilities.两家长期护理机构中跌倒与伤害最小数据集项目的验证
J Am Geriatr Soc. 2021 Apr;69(4):1099-1100. doi: 10.1111/jgs.16974. Epub 2020 Dec 7.
3
Comparative effectiveness of denosumab, teriparatide, and zoledronic acid among frail older adults: a retrospective cohort study.地诺单抗、特立帕肽和唑来膦酸在体弱老年人中的比较疗效:一项回顾性队列研究。
Osteoporos Int. 2021 Mar;32(3):565-573. doi: 10.1007/s00198-020-05732-2. Epub 2021 Jan 7.
4
Are Nursing Home Residents With Dementia Appropriately Treated for Fracture Prevention?养老院痴呆症患者的骨折预防治疗是否恰当?
J Am Med Dir Assoc. 2021 Jan;22(1):28-35.e3. doi: 10.1016/j.jamda.2020.11.019. Epub 2020 Dec 13.
5
Rates, determinants and success of implementing deprescribing in people with type 2 diabetes: A scoping review.在 2 型糖尿病患者中实施药物减量的比率、决定因素和成功率:范围综述。
Diabet Med. 2021 Feb;38(2):e14408. doi: 10.1111/dme.14408. Epub 2020 Oct 2.
6
Understanding Medicare ACO Adoption in the Context of Market Factors.理解市场因素背景下的医疗保险 ACO 采用
Popul Health Manag. 2021 Jun;24(3):360-368. doi: 10.1089/pop.2020.0060. Epub 2020 Aug 10.
7
Implementation of a fracture liaison service and its effects on osteoporosis treatment adherence and secondary fracture at a tertiary care academic health system.骨折联络服务的实施及其对三级保健学术医疗系统中骨质疏松症治疗依从性和二次骨折的影响。
Arch Osteoporos. 2020 May 28;15(1):80. doi: 10.1007/s11657-020-00736-1.
8
The REDCap consortium: Building an international community of software platform partners.REDCap 联盟:构建软件平台合作伙伴的国际社区。
J Biomed Inform. 2019 Jul;95:103208. doi: 10.1016/j.jbi.2019.103208. Epub 2019 May 9.
9
Health Outcomes of Deprescribing Interventions Among Older Residents in Nursing Homes: A Systematic Review and Meta-analysis.养老院老年居民药物减量干预的健康结局:系统评价和荟萃分析。
J Am Med Dir Assoc. 2019 Mar;20(3):362-372.e11. doi: 10.1016/j.jamda.2018.10.026. Epub 2018 Dec 21.
10
Effect of Bisphosphonates on Fracture Outcomes Among Frail Older Adults.双膦酸盐对虚弱老年人骨折结局的影响。
J Am Geriatr Soc. 2019 Apr;67(4):768-776. doi: 10.1111/jgs.15725. Epub 2018 Dec 21.